Cadila Pharmaceuticals and Singapore-based Wellesta Holdings have signed an MoU to establish a joint venture focused on expanding access to high-quality healthcare solutions across Southeast Asia and other emerging markets.
Cadila Pharmaceuticals | 01/07/2026 | By News Bureau | 114
Biscado enters India's beta-blocker therapy space, addressing the growing burden of heart disease
Cadila Pharmaceuticals launches Biscado (Bisoprolol) for cardiovascular disease management in India
Cadila Pharmaceuticals | 11/06/2025 | By Darshana | 232
Cadila Pharmaceuticals creates ? Collaboration Vertical ? to drive synergies, growth
The new vertical will work in close collaboration with different verticals of the company and group
Cadila Pharmaceuticals | 09/08/2022 | By Sudeep Soparkar | 2042
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy